EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:63115 - fingolimod
| Formula | C19H33NO2 |
| Net Charge | 0 |
| Average Mass | 307.478 |
| Monoisotopic Mass | 307.25113 |
| SMILES | CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1 |
| InChI | InChI=1S/C19H33NO2/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-22/h9-12,21-22H,2-8,13-16,20H2,1H3 |
| InChIKey | KKGQTZUTZRNORY-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | antiviral agent A substance that destroys or inhibits replication of viruses. sphingosine-1-phosphate receptor agonist An agonist that binds to and activates sphingosine 1-phosphate receptors. CB1 receptor antagonist An antagonist that binds to and deactivates type 1 cannabinoid receptors. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. |
| Applications: | prodrug A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. anti-inflammatory agent Any compound that has anti-inflammatory effects. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. antipsychotic agent Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. anti-asthmatic agent Any compound that has anti-asthmatic effects. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| fingolimod (CHEBI:63115) has role anti-asthmatic agent (CHEBI:65023) |
| fingolimod (CHEBI:63115) has role anti-inflammatory agent (CHEBI:67079) |
| fingolimod (CHEBI:63115) has role antineoplastic agent (CHEBI:35610) |
| fingolimod (CHEBI:63115) has role antipsychotic agent (CHEBI:35476) |
| fingolimod (CHEBI:63115) has role antiviral agent (CHEBI:22587) |
| fingolimod (CHEBI:63115) has role CB1 receptor antagonist (CHEBI:73416) |
| fingolimod (CHEBI:63115) has role immunosuppressive agent (CHEBI:35705) |
| fingolimod (CHEBI:63115) has role ophthalmology drug (CHEBI:66981) |
| fingolimod (CHEBI:63115) has role prodrug (CHEBI:50266) |
| fingolimod (CHEBI:63115) has role sphingosine-1-phosphate receptor agonist (CHEBI:63114) |
| fingolimod (CHEBI:63115) is a aminodiol (CHEBI:22501) |
| fingolimod (CHEBI:63115) is a benzenes (CHEBI:22712) |
| fingolimod (CHEBI:63115) is a organic molecular entity (CHEBI:50860) |
| fingolimod (CHEBI:63115) is a primary amino compound (CHEBI:50994) |
| fingolimod (CHEBI:63115) is conjugate base of fingolimod(1+) (CHEBI:63113) |
| Incoming Relation(s) |
| 2-amino-2-(methoxymethyl)-4-(4-octylphenyl)butan-1-ol (CHEBI:167708) has functional parent fingolimod (CHEBI:63115) |
| fingolimod phosphate (CHEBI:73420) has functional parent fingolimod (CHEBI:63115) |
| fingolimod(1+) (CHEBI:63113) is conjugate acid of fingolimod (CHEBI:63115) |
| IUPAC Name |
|---|
| 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol |
| INNs | Source |
|---|---|
| fingolimod | WHO MedNet |
| fingolimod | KEGG DRUG |
| fingolimod | WHO MedNet |
| fingolimodum | WHO MedNet |
| Synonyms | Source |
|---|---|
| FTY-720 | DrugCentral |
| FTY720 | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| 4167 | DrugCentral |
| D10001 | KEGG DRUG |
| DB08868 | DrugBank |
| Fingolimod | Wikipedia |
| Registry Numbers | Sources |
|---|---|
| Reaxys:7811195 | Reaxys |
| CAS:162359-55-9 | ChemIDplus |
| CAS:162359-55-9 | KEGG DRUG |
| Citations |
|---|